Arcus Biosciences stock gains on TD Cowen buy rating

Arcus Biosciences (RCUS) stock rose 3.4% after TD Cowen initiated coverage with a Buy rating, citing casdatifan's clinical profile. Analysts highlight its 15.1-month median progression-free survival vs. 5.6 months for Welireg. Arcus reported Q2 2026 revenue of $41M, beating estimates. The stock has a consensus Moderate Buy rating. Broader market gains also supported the move.

Arcus Biosciences, Inc. (RCUS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update August 5, 2026 • Arcus executes on strategy to establish casdatifan as a backbone therapy across each line of treatment for clear cell renal cell carcinoma (ccRCC), includi

CoreWeave, with 51 data centers and $72.1B in debt, faces a 60% default probability. Its stock dropped 24% as investors question its AI data center business model. Oracle also sees bond sell-offs, though less severe. Barclays reports a 50% surge in AI-related corporate bond credit spreads over six months. Permitting issues delay data center projects for Oracle and Blue Owl.

Samsung Electronics (005930.KS) and SK hynix (000660.KS) saw their worst weekly share price drops since 2008, driven by heavy foreign selling. Samsung fell 17.8% to 215,500 won, while SK hynix dropped 24.3% to 1.272 million won. Foreign investors sold 3.4763 trillion won and 5.3565 trillion won of their shares, respectively. Analysts are divided on future prospects, with some citing strong earnings and others warning of continued volatility.

Michael Saylor, founder of Strategy Inc. (MSTR), hinted at more Bitcoin purchases. As of mid-October 2026, the company held 848,250 BTC, valued at $69.45B. However, it recently reduced Bitcoin buys, focusing on repurchasing preferred shares and maintaining liquidity. MSCI may exclude MSTR from indexes, risking $2.8B in outflows. MSTR stock fell 9.56% to $136.83, trading below its net asset value.

Geopolitical tensions in the Strait of Hormuz have caused oil prices to surge, leading to inflation and a crisis in the US banking sector. According to Bloomberg, Bank of America (BAC), State Street (STT), and Citigroup (C) shares dropped 18%, 14%, and 10% respectively. The Fed raised rates to 4% to combat inflation, further straining banks. The KBW index of major US banks fell 13% from its August peak, marking its longest decline since 2008.